Aseptically Prepared Systemic Anti-Cancer Therapy Medicines
- Hankija
- Mid South Essex NHS Foundation Trust
- Avaldatud
- 2026-10-26
- Tähtaeg
- Pole esitatud
- Allikad
- UK_FTS
- Väärtus
- Pole esitatud
Kirjeldus
Kirjeldus on allika keeles.
This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.
Liikmesus
Teadete eelvaated on tasuta. Ametlike teadete ja dokumentide lingid, ehitusload ning isiklik MCP juurdepääs nõuavad aktiivset tasulist liikmesust.
Loe